CTH and glioblastoma: While this represents gene expression on an mRNA level and not protein levels nor enzymatic activity (specifically that of CGL), it offers a clinical basis supporting our hypothesis that endogenously produced H2S acts as a GBM suppressor that is modified by age and/or oncologic disease status.